GLOBAL

Announcing leadership changes at GLOBAL

October 6, 2025
GLOBAL

We wanted to share with our clients and partners some recent changes here at GLOBAL Regulatory Writing and Consulting. Matt Longhurst and Sarra de Valence have both left GLOBAL effective October 1st. We thank them for their years of service and dedication!

Matt joined GLOBAL in 2018 and played an important role during a period of significant change and growth. Together, we navigated the uncertainty of the early years of the COVID pandemic while keeping employee safety and business continuity at the forefront. His collaborative approach helped strengthen internal connections and client relationships. We appreciate his contributions and wish him the best in his next chapter.

Sarra joined GLOBAL in 2020 and made a lasting impact on the team. She played a key role leading our Medical Device team and supporting our writers in producing their best work. Her confident leadership and deep subject matter expertise inspired those around her to achieve outstanding results. We are grateful for her contributions and wish her the very best in her next chapter.

Moving forward, we are excited to announce the return of our founder to the CEO position. Emily Stephens launched GLOBAL in 2014 with a purpose – to create a company that treated workers with respect, loyalty, and deeply advocated for their well-being. Returning to the lead our company in this next chapter, Emily is focused on continuing to build on the past decade of growth and influence. Our teams are made of the best medical writers in the industry, and their performance delivers the best results. We are excited to continue to serve our clients with commitment to balance, collaboration, and excellence. From navigating complex regulatory pathways to delivering tailored solutions, this team leads with both expertise and empathy, shaping a company where clients and employees thrive together.

Please join us in thanking Matt and Sarra for their many contributions, and welcoming back Emily to drive us forward into 2026 and beyond!

Read More Recent News from GLOBAL

September 25, 2025

Join GLOBAL at RAPS Convergence 2025!

August 7, 2025

Announcing new Director of BioPharma Regulatory Affairs - Julie Matison

April 2, 2024

GLOBAL Regulatory Writing & Consulting - New CEO

Let’s Get Started

GLOBAL provides trusted regulatory consulting , writing, and technology solutions to help manufacturers bring products to patients at a life saving pace. We’ll be with you every step of the way.

BOOK a CONSULTATION